Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review

被引:0
|
作者
Moss, Kasey [1 ]
Gitman, Victor [2 ]
Sanchez, M. Ines Pinto [3 ,4 ]
Oczkowski, Simon [1 ,5 ]
Armstrong, David [4 ,6 ]
Jayakumar, Saumya [7 ,8 ]
Karvellas, Constantine Jason [8 ]
Selzner, Nazia [9 ]
Dionne, Joanna [10 ,11 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada
[3] McMaster Univ, Div Gastroenterol, Dept Med, Hamilton, ON, Canada
[4] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada
[5] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[6] McMaster Univ, Div Gastroenterol, Dept Med, Hamilton, ON, Canada
[7] Univ British Columbia, Div Gastroenterol, Dept Med, Vancouver, BC, Canada
[8] Univ Alberta, Div Gastroenterol, Dept Med, Edmonton, AB, Canada
[9] Univ Toronto, Div Gastroenterol, Dept Med, Toronto, ON, Canada
[10] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Dept Med, Hamilton, ON, Canada
[11] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Med, Hamilton, ON, Canada
来源
BMJ OPEN | 2024年 / 14卷 / 04期
关键词
Gastroenterology; NUTRITION & DIETETICS; Hepatology; Obesity; HEPATIC STEATOSIS; INDIVIDUALS; PREVALENCE; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Metabolic dysfunction-associated fatty liver disease (MASLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease worldwide. Given that there is no pharmacological treatment for MASLD, it is imperative to understand whether lifestyle modifications may improve biochemical and pathological outcomes. One commonly proposed dietary modification is the Mediterranean diet; however, vegetarianism may also be a promising intervention. Vegetarianism has been shown to be associated with reduced morbidity and mortality in metabolic syndrome outcomes in coronary artery disease and diabetes; however, the relationship between vegetarian diet and MASLD is less clear. In this scoping review, we will provide a comprehensive overview of the current body of evidence related to a vegetarian diet and MASLD. Methods and analysis The aim of this scoping review is to describe and summarise the current body of evidence related to MASLD and a vegetarian diet. This review will be conducted using Arksey and O'Malley's framework. The literature review will be conducted using the following databases: SCOPUS, Web of Science, CINAHL-Plus, Cochrane Library and Medline. No restriction will be made on publication date. Included studies will encompass clinical trials and observational designs that examine effects or association of vegetarian diet in adults (>= 16 years) and report on the incidence, prevalence or progression of MASLD. Grey literature, non-human studies and articles focusing on changes in a specific food or nutraceutical will be excluded. Articles must have an English-language abstract available to be considered for inclusion. Screening and data extraction will be conducted by two independent reviewers. The findings will be summarised with descriptive statistics. Ethics and dissemination Approval from a medical ethics committee is not required for this review. Once the review is complete, the findings will be submitted to a peer-reviewed journal.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
    Samanta, Arghya
    Sen Sarma, Moinak
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (04)
  • [2] Metabolic dysfunction-associated steatotic liver disease in children
    Goyal, Nidhi P.
    Xanthakos, Stavra
    Schwimmer, Jeffrey B.
    GUT, 2025, : 669 - 677
  • [3] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    MATURITAS, 2024, 186
  • [4] Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review
    Joo, Sae Kyung
    Kim, Won
    EWHA MEDICAL JOURNAL, 2024, 47 (02):
  • [5] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [6] Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Cazac, Georgiana-Diana
    Mihai, Bogdan-Mircea
    Stefanescu, Gabriela
    Gilca-Blanariu, Georgiana-Emmanuela
    Mihai, Catalina
    Grigorescu, Elena-Daniela
    Onofriescu, Alina
    Lacatusu, Cristina-Mihaela
    NUTRIENTS, 2024, 16 (13)
  • [7] Update in lean metabolic dysfunction-associated steatotic liver disease
    Sato-Espinoza, Karina
    Chotiprasidhi, Perapa
    Huaman, Mariella R.
    Diaz-Ferrer, Javier
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 452 - 464
  • [8] Endocrinologist's crucial role in metabolic dysfunction-associated steatotic liver disease: a comprehensive review
    Reytor-Gonzalez, Claudia
    Annunziata, Giuseppe
    Campuzano-Donoso, Martin
    Morales-Lopez, Tania
    Basantes-Tituana, Carmen
    Fasci-Spurio, Federica
    Verde, Ludovica
    Muscogiuri, Giovanna
    Barrea, Luigi
    Frias-Toral, Evelyn
    Simancas-Racines, Daniel
    MINERVA ENDOCRINOLOGY, 2025,
  • [9] Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
    Abenavoli, Ludovico
    Statsenko, Michael
    Scarlata, Giuseppe Guido Maria
    Morano, Domenico
    Myazin, Roman
    Emelyanov, Dmitriy
    LIVERS, 2024, 4 (04): : 495 - 506
  • [10] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Orfanidou, Myrsini
    Polyzos, Stergios A.
    MEDICINA-LITHUANIA, 2025, 61 (01):